Novel anti-inflammatory agents

I. M. Adcock (London, United Kingdom)

Source: Annual Congress 2009 - Emerging trends in the therapy of COPD
Session: Emerging trends in the therapy of COPD
Session type: Symposium
Number: 3033
Disease area: Airway diseases

Slide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. M. Adcock (London, United Kingdom). Novel anti-inflammatory agents. Annual Congress 2009 - Emerging trends in the therapy of COPD

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Macrolides as anti-inflammatory agents in CAP
Source: Eur Respir Monogr 2014; 63: 243-255
Year: 2014


In vitro pharmacological profile of SMP-028, a novel potent anti-inflammatory agent
Source: Annual Congress 2010 - Models of airways disease
Year: 2010

Late Breaking Abstract - Anti-inflammatory activity of novel transtilbene sulfonamide analogues as potential novel therapeutic agents for inflammatory lung disease
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019


LATE-BREAKING ABSTRACT: GW870086: A potent anti-inflammatory glucocorticoid with a novel pharmacological profile
Source: Annual Congress 2013 –Hot topics on airway diseases: new horizons in treatment
Year: 2013


Potential role of antidepressants as part of anticancer therapy
Source: Annual Congress 2011 - Palliation and morbidity in lung cancer patients
Year: 2011


How to disrupt malicious LC-fILD pathways: antifibrotic agents as a promising therapeutic approach
Source: Virtual Congress 2021 – Lung cancer and fibrotic interstitial lung diseases: a challenging association for pulmonologists
Year: 2021


Mucolytics and anti-inflammatory lung treatments
Source: ERS course 2015
Year: 2015


Drugs anti-inflammatories
Source: Virtual Congress 2020 – Management
Year: 2020


Anti-inflammatory treatment
Source: International Congress 2017 – PG3 Bronchiectasis
Year: 2017


A combination of thyme and ivy exerts potent anti-inflammatory and mucus-normalizing activity in vivo and inhibits 5-LO and PDE4
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014

Preclinical anti-inflammatory activity and safety profile of the novel glucocorticoid ciclesonide
Source: Eur Respir J 2001; 18: Suppl. 33, 147s
Year: 2001

Anti-inflammatory, antioxidant and immunomodulatory effects of curcumin in sensitized rat
Source: International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology
Year: 2017


Nonsteroidal anti-inflammatory drugs in community-acquired pneumonia
Source: Eur Respir J 2015; 46: 875-876
Year: 2015


Nonsteroidal anti-inflammatory drugs in community-acquired pneumonia
Source: Eur Respir J 2015; 46: 876-877
Year: 2015


Update on anti-inflammatory therapy in asthma
Source: Research Seminar 2012 - Pulmonary inflammation in paediatric respiratory disease
Year: 2012


Do long-acting β2-adrenoceptor agonists enhance the anti-inflammatory effect of glucocorticoids in asthma?
Source: Eur Respir J 2001; 17: 1059-1061
Year: 2001